But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

Research in mice identifies protein responsible for regulating gut movement in response to pressure, exercise, and ...

ILMN and Nashville Biosciences, LLC (NashBio) recently announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. The insights from the AGD ...

As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...

The global axial spondyloarthritis market is set for significant growth, with forecasts indicating a robust CAGR of 14.8% during the period from 2022 to 2028. This growth is primarily attributed to ...

After every meal, the intestines perform an action called peristalsis — moving food through their hollow interiors with coordinated contractions and ...

Analysts have taken a lukewarm stance on Bristol-Myers Squibb, dishing out a mixed bag of stock ratings that’s less “fireworks” and more “flickering candle.” Out of nineteen brokerages, eleven slapped ...